tiprankstipranks

Khalid Islam Insider Profile

4 Followers
Khalid Islam, Director at Immunomedics, holds 930.78K shares in Gain Therapeutics (Ticker: GANX), holds 213.82K shares in Fennec Pharmaceuticals (Ticker: FENC), holds 193.40K shares in Processa Pharmaceuticals (Ticker: PCSA). Most recently, Khalid Islam Bought ― shares of Gain Therapeutics on Aug 12, 2024 for an estimated value of 49.50K.
tipranks
Khalid Islam

Khalid Islam
Immunomedics (IMMU)
Director

Not Ranked
Khalid Islam has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
55.11%
39.16%
5.73%
A breakdown of Khalid Islam's holdings

Insider Roles

Gain Therapeutics
(GANX)
EC, Director
Fennec Pharmaceuticals
(FENC)
Director
Processa Pharmaceuticals
(PCSA)
Director
Roles that Khalid Islam holds in companies

Most Profitable Insider Trade

Stock:
Gain Therapeutics
(GANX)
Rating:Informative Buy
Date:Aug 12, 2024 - Today
Return:+136.10%
The most profitable trade made by Khalid Islam

Khalid Islam's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
IMMU
Immunomedics
Oct 23, 2020
Uninformative Sell
$0.00
Fennec Pharmaceuticals
Nov 16, 2023
Director
Uninformative Buy
441.40K
$1.14M
Processa Pharmaceuticals
Apr 04, 2022
Director
Uninformative Buy
$166.32K
Gain Therapeutics
Aug 12, 2024
EC, Director
Informative Buy
49.50K
$1.60M
List of latest transactions for each holding click on a transaction to see Khalid Islam's performance on stock

Khalid Islam insider profile FAQ

What is the percentage of profitable transactions made by Khalid Islam?
The percentage of profitable transactions made by Khalid Islam is ―.
    What is the average return per transaction made by Khalid Islam?
    The average return per transaction made by Khalid Islam is ―.
      What stocks does Khalid Islam hold?
      Khalid Islam holds: IMMU, FENC, PCSA, GANX stocks.
        What was Khalid Islam’s latest transaction?
        Khalid Islam latest transaction was an Informative Buy of $49.50K.
          What was Khalid Islam's most profitable transaction?
          Khalid Islam’s most profitable transaction was an Informative Buy of GANX stock on August 12, 2024. The return on the trade was 136.10%.
            What is Khalid Islam's role in Immunomedics?
            Khalid Islam's role in Immunomedics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.